Do you want to know more on the HCPs behaviour changes during COVID-19 lockdown? Let Fonny Schenck (CEO, Across Health) walk you through the findings of our most recent Navigator Spotcheck (302 oncologists in EU5 + US). Some of the key questions of our second COVID-related webinar: - Which channels shifted most in terms of reach, impact and frequency vs Q4 2019? - What kind of pharma content are HCPs looking for online? - Are there key differences between geo markets – and between HCP segments? - How do oncologists see the future role of the rep? - Which companies are “best-in-class”? We trust this session will help you reimagine the future of customer engagement in biopharma! For the recorded webinar and the full deck please visit: https://bit.ly/3ewb0zX

1. 28/05/2020Proprietary and Confidential Information© Across Health1
Reimagine customer engagement: COVID-19 & beyond
Webinar 2
19 May 2020
NOTE
This is a rapidly evolving situation, so key
results & ideas may change over time –
and lead to different conclusions

2. 28/05/2020Proprietary and Confidential Information© Across Health2
Agenda
1 The sample (302 oncologists, EU5+US)
2 OCE - Emerging changes/trends at the customer level (“demand”)
3 OCE - Emerging changes/trends at the pharma level (“supply”)
4 Reimagine the future

3. 28/05/2020Proprietary and Confidential Information© Across Health3

4. 28/05/2020Proprietary and Confidential Information© Across Health4
The greatest danger in times of turbulence is
not the turbulence, it is to act with
yesterday’s logic.
Peter Drucker

5. 28/05/2020Proprietary and Confidential Information© Across Health5
Across Health ran 2 big Spotchecks: one mid March & one end April
Navigator Spotcheck 1
(13-17 March 2020, multiple TAs)
Navigator Spotcheck 3
(17-30 April 2020 EU5+US – oncology)
1.
2.
Where appropriate, we compared with the 2019 Navigator365 Onco EU5+US data (n = 610)

6. 28/05/2020Proprietary and Confidential Information© Across Health6
Agenda
1 The sample (302 oncologists, EU5+US)
2 OCE - Emerging changes/trends at the customer level (“demand”)
3 OCE - Emerging changes/trends at the pharma level (“supply”)
4 Reimagine the future

7. 28/05/2020Proprietary and Confidential Information© Across Health7
It takes on average 66 days to change behaviour
“COVID-19 has accelerated the WFH trend by 5 years” (Deloitte)

8. 28/05/2020Proprietary and Confidential Information© Across Health8
Overall, oncologists spend a significant time online for professional
purposes – but appear to have reached a plateau vs 2019
90 mins WEEKDAY
75 mins WEEKEND DAY
Navigator Spotcheck 3 2020, n=302
NOTE: this seems to be a (high) plateau; Spain & Italy are highest (96+ mins),
Germany and UK lowest (80 mins)

9. 28/05/2020Proprietary and Confidential Information© Across Health9
Only 16% feel pharma digital content is up strongly vs 1yr ago
Navigator Spotcheck 3 2020, n=302
EU5+US
2%
42%
38%
16%
2%
Became worse
No change
Slight improvement
Strong improvement
No opinion
IMPROVEMENT IN ONLINE CONTENT VS 12 MTHS AGO -
ONCO, ALL COUNTRIES

10. 28/05/2020Proprietary and Confidential Information© Across Health10
Importance of pharma digital increases, satisfaction is decreasing…
But there is still a huge gap – and only a few companies are pushing up the average
59%
Finds digital offerings from
pharma important (55%) +6%
36%
Is satisfied with pharma’s
digital offerings (38%) -4%
58%
Finds only some pharmacos
are offering relevant digital
content (56%)
+4%
% in brackets are from the 2019 set
EU5+US
Navigator Spotcheck 3 2020, n=302

11. 28/05/2020Proprietary and Confidential Information© Across Health11
Averages can deceive…
Navigator Spotcheck 3 2020, n=302
2020 2019
% Important % Satisfied % Important % Satisfied
FR 55% 37% 46% 39%
DE 51% 16% 43% 22%
IT 71% 40% 69% 44%
SP 74% 58% 78% 41%
UK 52% 36% 56% 36%
US 48% 30% 45% 43%
In less than 6 months, behaviours are changing
Decrease by 10+% vs Q4 2019
Increase by 10+% vs Q4 2019
• The segment that finds digital important is a majority (52-74%)
• Conservative markets see a strong increase in importance (except US& UK)
• Satisfaction drops – except in Spain

12. 28/05/2020Proprietary and Confidential Information© Across Health12
Agenda
1 The sample (302 oncologists, EU5+US)
2 OCE - Emerging changes/trends at the customer level (“demand”)
3 OCE - Emerging changes/trends at the pharma level (“supply”)
4 Reimagine the future

13. 28/05/2020Proprietary and Confidential Information© Across Health13
Access the full deck and watch the recording:
across.health/event/reimagine-the-future-of-customer-
engagement-april-navigator-spotcheck